Human cloning and embryonic stem cell research have failed to produce any usable medical advances so far.  Private investment capital has dried up for these fruitless pursuits.  

Diabetes research organizations are misguided in pushing for passage in the Illinois Senate of HB 3589, called the Stem Cell Research Act.  For truth in labeling, it should be identified as the human cloning bill.  Why encourage more effort pursuing a dead end when a more promising alternative exists?

Let researchers who want to continue pursuing this unethical dead end move to New Jersey or California.  The legislatures of those states were already duped into support of human cloning and embryonic stem cell research by special interests pushing the dubious benefits of so-called therapeutic cloning.  Such research causes the death of human embryos to obtain their stem cells.